The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Cardiovascular disease in dialysis patients
Open accessAbstract
Cardiovascular disease (CVD) is a highly common complication and the first cause of death in patients with end-stage renal disease (ESRD) on haemodialysis (HD). In this population, mortality due to CVD is 20 times higher than in the general population and the majority of maintenance HD patients have CVD. This is likely due to ventricular hypertrophy as well as non-traditional risk factors, such as chronic volume overload, anaemia, inflammation, oxidative stress, chronic kidney disease-mineral bone disorder and other aspects of the 'uraemic milieu'. Better understanding the impact of these numerous factors on CVD would be an important step for prevention and treatment. In this review we focus non-traditional CVD risk factors in HD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213 · cited 1×
“There is evidence that uraemic factors may be implicated in the pathogenesis of CV disease in HD patients, since CV survival improves after kidney transplantation even in high-risk patients [4, 5].”
BackgroundFGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027 · cited 1×
“FGF23 caused pathological hypertrophy of isolated rat cardiomyocytes via FGF receptor– dependent activation of the calcineurin–nuclear factor of activated T cells signalling pathway, but this effect was independent of a-klotho [45].”
BackgroundFox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61350-6 · Cited by 1,401
Ketteler, M., Block, G. A., Evenepoel, P., Fukagawa, M., Herzog, C. A., McCann, L., Moe, S. M., Shroff, R., Tonelli, M. A., Toussaint, N. D., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.04.006 · Cited by 1,016
Herzog, C. A., Asinger, R. W., Berger, A. K., Charytan, D. M., Díez, J., Hart, R. G., Eckardt, K.-U., Kasiske, B. L., McCullough, P. A., Passman, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 922
Mahmoodi, B. K., Matsushita, K., Woodward, M., Blankestijn, P. J., Cirillo, M., Ohkubo, T., Rossing, P., Sarnak, M. J., Stengel, B., Yamagishi, K., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61272-0 · Cited by 452
Uremic toxins originating from colonic microbial metabolism
Evenepoel, P., Meijers, B. K. I., Bammens, B. R. M., & Verbeke, K. (2009) · Kidney International · doi:10.1038/ki.2009.402 · Cited by 445
Hu, M.-C., Shi, M., Zhang, J., Quiñones, H., Kuro-o, M., & Moe, O. W. (2010) · Kidney International · doi:10.1038/ki.2010.328 · Cited by 386
Ravani, P., Tripepi, G., Malberti, F., Testa, S., Mallamaci, F., & Zoccali, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010076 · Cited by 381
p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease
Meijers, B. K. I., Claes, K., Bammens, B., de Loor, H., Viaene, L., Verbeke, K., Kuypers, D., Vanrenterghem, Y., & Evenepoel, P. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07971109 · Cited by 316
Free p-cresol is associated with cardiovascular disease in hemodialysis patients
Meijers, B. K. I., Bammens, B., De Moor, B., Verbeke, K., Vanrenterghem, Y., & Evenepoel, P. (2008) · Kidney International · doi:10.1038/ki.2008.31 · Cited by 315
Oxidative Stress in Hemodialysis Patients: A Review of the Literature
Liakopoulos, V., Roumeliotis, S., Gorny, X., Dounousi, E., & Mertens, P. R. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3081856 · Cited by 297
Vascular calcification in chronic kidney disease: different bricks in the wall?
Vervloet, M., & Cozzolino, M. (2017) · Kidney International · doi:10.1016/j.kint.2016.09.024 · Cited by 265
Self-citationXie, J., Yoon, J., An, S.-W., Kuro-o, M., & Huang, C.-L. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014040325 · Cited by 263
The role of phosphate in kidney disease
on behalf of the ERA–EDTA Working Group on Chronic Kidney Disease–Mineral and Bone Disorders and the European Renal Nutrition Working Group, Vervloet, M. G., Sezer, S., Massy, Z. A., Johansson, L., Cozzolino, M., & Fouque, D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.164 · Cited by 251
Self-citationUremic Toxicity of Advanced Glycation End Products in CKD
Stinghen, A. E. M., Massy, Z. A., Vlassara, H., Striker, G. E., & Boullier, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101047 · Cited by 242
Songia, P., Porro, B., Chiesa, M., Myasoedova, V., Alamanni, F., Tremoli, E., & Poggio, P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3575348 · Cited by 235
on behalf of the European Uremic Toxin (EUTox) Work Group, Desjardins, L., Liabeuf, S., Renard, C., Lenglet, A., Lemke, H.-D., Choukroun, G., Drueke, T. B., & Massy, Z. A. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1838-0 · Cited by 219
Kitagawa, M., Sugiyama, H., Morinaga, H., Inoue, T., Takiue, K., Ogawa, A., Yamanari, T., Kikumoto, Y., Uchida, H. A., Kitamura, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056695 · Cited by 195
The Rehabilitation Role in Chronic Kidney and End Stage Renal Disease
Intiso, D. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000355795 · Cited by 187
Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
Sun, J., Axelsson, J., Machowska, A., Heimbürger, O., Bárány, P., Lindholm, B., Lindström, K., Stenvinkel, P., & Qureshi, A. R. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10441015 · Cited by 183
Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease
Moradi, H., Sica, D. A., & Kalantar-Zadeh, K. (2013) · American Journal of Nephrology · doi:10.1159/000351758 · Cited by 179
The Involvement of Oxidative Stress in the Progression of Renal Injury
Haugen, E., & Nath, K. A. (1999) · Blood Purification · doi:10.1159/000014377 · Cited by 144
Chitalia, V. C., Shivanna, S., Martorell, J., Balcells, M., Bosch, I., Kolandaivelu, K., & Edelman, E. R. (2012) · Circulation · doi:10.1161/circulationaha.112.118174 · Cited by 139
Uremic toxicity of indoxyl sulfate.
Niwa, T. (2010) · PubMed · doi:10.18999/nagjms.72.1-2.1 · Cited by 139
Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature
Liakopoulos, V., Roumeliotis, S. K., Gorny, X., Eleftheriadis, T., & Mertens, P. R. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3494867 · Cited by 138
Urea, a true uremic toxin: the empire strikes back
Lau, W. L., & Vaziri, N. D. (2016) · Clinical Science · doi:10.1042/cs20160203 · Cited by 124
Shivanna, S., Kolandaivelu, K., Shashar, M., Belghasim, M., Al-Rabadi, L. F., Balcells, M., Zhang, A., Weinberg, J., Francis, J. M., Pollastri, M. P., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121241 · Cited by 120
Kaminski, T. W., Pawlak, K., Karbowska, M., Myśliwiec, M., & Pawlak, D. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0457-1 · Cited by 118
P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro
Dou, L., Anfosso, F. J., Sabatier, F., Moal, V., Glorieux, G., Smet, R. D., Vanholder, R., Dignat‐George, F., Sampol, J., Berland, Y., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-07-0491 · Cited by 99
Gut microbiota, hypertension and chronic kidney disease: Recent advances
Sircana, A., Michieli, F. D., Parente, R., Framarin, L., Leone, N., Berrutti, M., Paschetta, E., Bongiovanni, D., & Musso, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.013 · Cited by 96
Wilcox, C. S. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.187310 · Cited by 95
The Cardiovascular Burden in End-Stage Renal Disease
Cozzolino, M. G., Galassi, A., Pivari, F., Ciceri, P., & Conte, F. (2017) · Contributions to nephrology · doi:10.1159/000479250 · Cited by 84
Self-citationKlotho: a novel regulator of calcium and phosphorus homeostasis
Huang, C.-L., & Moe, O. W. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0950-5 · Cited by 83
Wang, Z., Jiang, A., Wei, F., & Chen, H. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0747-y · Cited by 82
Emrich, I. E., Zawada, A. M., Martens‐Lobenhoffer, J., Fliser, D., Wagenpfeil, S., Heine, G. H., & Bode‐Böger, S. M. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1172-4 · Cited by 76
NESRALLAH, G. E., Mustafa, R. A., MacRae, J. M., Pauly, R. P., Perkins, D. N., Gangji, A. S., Rioux, J., Steele, A., Suri, R. S., Chan, C. T., et al. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.351 · Cited by 75
Liabeuf, S., Okazaki, H., Desjardins, L., Fliser, D., Goldsmith, D. J. A., Covic, A. C., Więcek, A., Ortíz, A., Martínez‐Castelao, A., Lindholm, B., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft368 · Cited by 66
New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease
Pedraza‐Chaverrí, J., Sánchez‐Lozada, L. G., Osorio‐Alonso, H., Tapia, E., & Scholze, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6043601 · Cited by 65
Pro: Cardiovascular calcifications are clinically relevant
Bover, J., Evenepoel, P., Ureña, P., Vervloet, M. G., Brandenburg, V. M., Mazzaferro, S., Covic, A. C., Goldsmith, D. J. A., Massy, Z. A., Cozzolino, M. G., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv020 · Cited by 56
Self-citationChen, M., Chang, C., & Liou, S.-Y. (1998) · Blood Purification · doi:10.1159/000014347 · Cited by 50
The Role of Cardiotonic Steroids in the Pathogenesis of Cardiomyopathy in Chronic Kidney Disease
Pavlović, D. (2014) · Nephron Clinical Practice · doi:10.1159/000363301 · Cited by 35
Kuźniewski, M., Fedak, D., Dumnicka, P., Stępień, E. Ł., Kuśnierz‐Cabala, B., Cwynar, M., & Sułowicz, W. (2016) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.03.003 · Cited by 28
Pichler, G., Haller, M. C., Kainz, A., Wolf, M. S., Redón, J., & Oberbauer, R. W. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw387 · Cited by 28
Barisione, C., Ghigliotti, G., Canepa, M., Balbi, M., Brunelli, C., & Ameri, P. (2015) · Current Drug Targets · doi:10.2174/1389450116666141230114500 · Cited by 26
Metadata
- Authors
- Cozzolino, M., Mangano, M., Stucchi, A., Ciceri, P., Conte, F., & Galassi, A.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10-01
- Volume
- 33
- Issue
- suppl_3
- Pages
- iii28-iii34
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2895682445
- Cited by
- 564
- References
- 46
- FWCI
- 26.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.